Publication date: Jul 17, 2023
The purpose of this study is to evaluate the safety and immunogenicity of MTBVAC in adolescents and adults living with and without HIV in South Africa
| Concepts | Keywords |
|---|---|
| Exam | Cells |
| Hvtn605a5421 | Cohort |
| Menopause | Cohorts |
| Tuberculosis | Count |
| Volunteers | Enrollment |
| Hiv | |
| Initiation | |
| Investigator | |
| Living | |
| Mtbvac | |
| Potential | |
| Pregnancy | |
| Prior | |
| Volunteers | |
| Years |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | BCG vaccine |
| drug | DRUGBANK | Etoperidone |
| disease | MESH | tuberculosis |
| pathway | KEGG | Tuberculosis |
| drug | DRUGBANK | Creatinine |
| drug | DRUGBANK | L-Alanine |
| drug | DRUGBANK | Hepatitis B Vaccine (Recombinant) |
| drug | DRUGBANK | Chorionic Gonadotropin (Human) |
Original Article
(Visited 1 times, 1 visits today)